The PI3K inhibitor BKM120 has potent antitumor activity in melanoma brain metastases in vitro and in vivo.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Friedegund Elke Meier, Heike Niessner, Jennifer Schmitz, Andreas Schmid, Carsten Calaminus, Bernd Pichler, Andrea Forschner, Keith Flaherty, Juergen Bernd Honegger, Reinhard Dummer, Ghazaleh Tabatabai, Benjamin Weide, Thomas K. Eigentler, Dirk Schadendorf, Leticia Quintanilla-Fend, Claus Garbe
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2345314741